ᓇᐃᑦᑐᒥᒃ ᑭᐅᔾᔪᑎ
ᐱᙳᐊᕈᑎᒥᒃ ᐊᑕᐅᓯᕐᒥᒃ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᖓ ᑕᑯᔭᐅᓯᒪᔪᖃᙱᑦᑐᖅ. ᖃᕋᓴᐅᔭᒃᑯᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐱᐅᓯᒋᐊᕈᑎᓂᒃ ᐱᓕᕆᖃᑦᑕᖅᑕᖏᓐᓂᒃ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑕᐅᔪᖅ. ACTIVE ᖃᐅᔨᓴᕐᓂᕐᒥ ᐊᑕᐅᓯᕐᒥ, ᓇᓗᓇᐃᔭᖅᓯᒪᔪᒥᒃ ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓄᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᓄᑦ, 20-ᓂ ᐅᑭᐅᓂ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᓯᒪᓂᖏᑦ ᐊᒥᓲᓂᖅᓴᐅᓚᐅᖅᐳᑦ, ᑖᓐᓇ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᑐᐃᓐᓇᖅ ᐊᑕᐅᓯᕐᒧᑦ. ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᐃᓅᔪᓄᑦ, ᑲᑎᙵᔪᓂ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᖅ ᒥᑭᔪᓂᒃ, ᓇᐃᑦᑐᓂᒃ ᐊᑐᖅᑕᐅᔪᓂᒃ ᐃᑲᔪᖅᑐᖅ. ᐱᙳᐊᕈᑎᑦ ᐱᐅᓯᒋᐊᕈᒪᓇᖅᑐᑦ ᖁᕕᐊᓱᒍᑎᒧᑦ ᐊᒻᒪ ᑲᑎᙵᓂᕐᒧᑦ.
- ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᖃᐅᔨᓴᕐᓃᑦ ᑕᑯᔭᖅᑐᑦ ᐃᓄᑦ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖏᓐᓂᒃ ᐱᓕᕆᖃᑦᑕᖅᑕᖏᓐᓂᒃ, ᐅᓪᓗᑕᒫᒧᑦ ᐃᓅᓯᕐᒧᑦ ᐊᑐᖅᑕᐅᓂᖓ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᖃᑦᑕᐅᙱᑦᑐᖅ.
- ACTIVE ᖃᐅᔨᓴᕐᓂᕐᒥ, ᓇᓗᓇᐃᔭᖅᓯᒪᔪᒥᒃ ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓄᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᓄᑦ ᐱᓕᕆᖃᑦᑕᖅᓯᒪᔪᑦ ᑭᓯᐊᓂ 20-ᓂ ᐅᑭᐅᓂ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᓯᒪᓂᖏᑦ ᐊᒥᓲᓂᖅᓴᐅᓚᐅᖅᐳᑦ. ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᓂᖃᙱᑦᑐᖅ, ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᑖᓐᓇ ᑕᑯᔭᐅᓯᒪᙱᓚᖅ.
- 2016-ᒥ, Lumosity-ᒧᑦ ᓴᓇᔨᖏᑦ $2 ᒥᓕᐊᓐ ᐊᑭᓕᖅᓱᖅᑕᐅᓚᐅᖅᐳᑦ FTC-ᒧᑦ ᐱᔾᔪᑎᖃᖅᑐᑎᒃ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖃᙱᑦᑐᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᕐᒧᑦ ᐅᖃᐅᓯᖃᕐᓂᕐᒧᑦ.
- ᐊᔪᕐᓇᖅᑐᓂᒃ ᒥᑭᔪᓂᒃ ᐊᒻᒪᓗ ᐊᑯᓐᓂᖓᓂ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᐃᓅᔪᓄᑦ, ᑲᑎᙵᔪᓂ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᖅ ᒥᑭᔪᓂᒃ, ᓇᐃᑦᑐᓂᒃ ᐊᑐᖅᑕᐅᔪᓂᒃ ᐃᑲᔪᖅᑐᖅ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᒻᒪ ᐅᖃᖃᑎᒌᓐᓂᕐᒧᑦ ᐃᓚᐅᖃᑕᐅᓂᕐᒧᑦ.
- Golden Moments ᐱᙳᐊᕈᑎᑦ ᖁᕕᐊᓱᒍᑎᒧᑦ ᐊᒻᒪ ᑲᑎᙵᓂᕐᒧᑦ ᐊᑐᖅᑕᐅᔪᑦ. ᒪᒪᕐᓂᐅᑎᙱᑦᑐᑦ ᐊᒻᒪ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓲᑦ ᐅᕝᕙᓘᓐᓃᑦ ᓱᒃᑲᓂᖅᓴᐅᑎᑕᐅᓲᑦ.
ᑕᕝᕙᓂ ᒪᒃᐱᒐᕐᒥ (9 ᐃᓚᖏᑦ)
- ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓲᑦ?
- “ᖃᓂᒋᔭᖓᓂ ᐊᑐᖅᑕᐅᓂᖅ” ᖃᓄᖅ ᑐᑭᓕᐅᖅᐸ, ᓱᒃᑲᐃᓐᓇᕐᒧᑦ ᐱᒻᒪᕆᐅᓪᓗᓂ?
- ᖃᐅᔨᓴᕐᓂᐅᔪᑦ ᑲᑎᑕᐅᓯᒪᔪᑦ ᖃᓄᖅ ᐅᖃᖅᐸᑦ ᖃᕋᓴᐅᔭᒃᑯᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ?
- ACTIVE ᖃᐅᔨᓴᕐᓂᖅ ᖃᓄᖅ ᓇᓗᓇᐃᖅᓯᓚᐅᖅᐸ?
- FTC ᖃᓄᖅ ᐅᖃᓚᐅᖅᐸ Lumosity-ᒧᑦ?
- ᐱᙳᐊᕈᑎᑦ ᐃᑲᔪᕈᓐᓇᖅᐸᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓅᔪᒥᒃ?
- ᐱᙳᐊᕈᑎᑦ ᐱᔭᐅᒻᒪᕆᐅᓲᑦ ᖃᓄᖅ?
- Golden Moments ᓇᓃᑦᑐᖅ
- ᒪᒪᕐᓂᐅᕐᑎᒧᑦ ᐅᖃᖃᑎᒌᓐᓂᖅ
ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᐊᑕᖏᖅᑐᑦ, ᐊᒥᓱᓂᓪᓗ ᐃᓱᒪᒋᔭᐅᓂᖅ ᒪᒃᑯᒃᑐᒥᒃ ᐃᓄᒃᑎᑑᖃᑦᑕᕐᓂᐊᕐᒪᖔᑦ ᐅᖃᐅᓯᖃᖅᑐᑦ. ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓅᔪᒥᒃ ᐸᐅᕐᓯᒪᒃᐸᑦ, ᐅᕝᕙᓘᓐᓃᑦ ᓇᖕᒥᓂᕆᔭᑦ ᐃᖅᑲᐅᒪᔭᕆᐊᖃᕐᓂᕐᒧᑦ ᐃᓱᒪᓕᒻᒪᒃᐸᑦ, ᐱᙳᐊᕈᑎᑦ ᐃᑲᔪᕐᓇᖅᐸᑦ ᐊᐱᖅᓱᕐᓂᖅ ᐃᓱᒪᒋᐊᖃᕐᓇᖅᑐᖅ. ᐅᕙᓂ ᖃᐅᔨᓴᕐᓂᖅ ᑕᑯᔭᖅᑐᖓ ᐊᑐᖅᑐᖅ, ᐃᑲᔪᖅᑕᐅᔪᓐᓇᖅᑐᑦ ᐊᒻᒪ ᐃᑲᔪᖅᑕᐅᔪᓐᓇᙱᑦᑐᑦ ᐃᓚᒋᔭᐅᓗᑎᒃ.
ᑖᓐᓇ ᑐᓴᕆᐊᕐᓂᖅ ᐊᑐᖅᑐᖅ, ᒪᒪᕐᓂᐅᑎᙱᑦᑐᖅ. ᑕᑯᓗᒍ ᒪᒪᕐᓂᐅᑎᒧᑦ ᐅᖃᐅᓯᖅ.
ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓲᑦ?
ᐱᙳᐊᕈᑎᒥᒃ ᐊᑕᐅᓯᕐᒥᒃ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᖓ ᓇᓗᓇᐃᖅᓯᒪᔪᖃᙱᑦᑐᖅ. National Institute on Aging (NIA) ᐅᖃᐅᑎᑦᑎᔪᖅ ᐃᓄᓐᓂᒃ ᐅᔾᔨᕆᔭᖃᕐᓂᕐᒧᑦ ᐅᖃᐅᓯᓄᑦ ᖃᕋᓴᐅᔭᒃᑯᑦ ᐊᒻᒪ ᐃᓐᑐᕋᓐᓈᒃᑯᑦ ᐱᙳᐊᕈᑎᑦ ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒥᒃ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑕᐅᔪᓐᓇᖅᑐᑦ ᐅᖃᐅᓯᖃᖅᑐᑦ, ᐊᒻᒪ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᓂᒃ ᓈᓴᐅᑎᓂᒃ ᐊᒥᓱᓂᖅᓴᐅᙱᑦᑐᑦ ᓂᐅᕕᐊᒃᓴᖃᕐᓂᕐᒧᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᓂᒃ ᐊᔾᔨᒌᙱᑦᑐᑦ (NIA ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᕐᒧᑦ).
ᑖᓐᓇ ᐱᙳᐊᕈᑎᑦ ᐊᑐᖅᑕᐅᔪᓐᓇᙱᑦᑐᑦ ᐅᖃᐅᓯᖃᙱᑦᑐᖅ. ᐱᒻᒪᕆᐅᓂᖏᑦ ᖁᕕᐊᓱᒍᑎᒥ, ᑲᑎᙵᓂᕐᒥ ᐊᒻᒪ ᐱᓕᕆᐊᒥ ᐃᓚᒋᔭᐅᔪᖅ, ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓴᐳᔾᔭᐅᓯᒪᓂᕐᒧᑦ ᐱᙱᑦᑐᖅ.
“ᖃᓂᒋᔭᖓᓂ ᐊᑐᖅᑕᐅᓂᖅ” ᖃᓄᖅ ᑐᑭᓕᐅᖅᐸ, ᓱᒃᑲᐃᓐᓇᕐᒧᑦ ᐱᒻᒪᕆᐅᓪᓗᓂ?
ᐱᓕᕆᐊᒥᒃ ᐱᓕᕆᖃᑦᑕᖅᐸᑦ, ᑕᒪᓐᓇ ᐱᓕᕆᐊᖅ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑕᐅᔪᖅ. ᖃᐅᔨᓴᖅᑏᑦ ᑖᓐᓇ “ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᑐᖅᑕᐅᓂᖅ” ᐅᖃᐅᑎᑦᑎᕗᑦ. ᐊᔪᕐᓇᓂᖅᓴᖅ ᐊᐱᖅᑐᖅ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖅ ᐊᑐᖅᑕᐅᓂᖓ ᐊᓯᖏᓐᓄᑦ ᐱᓕᕆᐊᓄᑦ ᐊᑐᖅᐸᒃ: ᖃᓂᒋᔭᖏᓐᓄᑦ ᐱᓕᕆᐊᓄᑦ (ᖃᓂᒋᔭᖓᓂ ᐊᑐᖅᑕᐅᓂᖅ) ᐅᕝᕙᓘᓐᓃᑦ ᐅᓪᓗᑕᒫᒧᑦ ᐃᓅᓯᕐᒧᑦ, ᓲᕐᓗ ᑲᑎᒪᓂᕐᓂᒃ ᐃᖅᑲᐅᒪᓂᖅ ᐅᕝᕙᓘᓐᓃᑦ ᑮᓇᐅᔭᓂᒃ ᐊᐅᓚᑦᑎᓂᖅ (ᐅᖓᓯᒃᑐᒥ ᐊᑐᖅᑕᐅᓂᖅ).
2016-ᒥ ᐊᖏᔪᖅ ᖃᐅᔨᓴᕐᓂᖅ ᖃᐅᔨᓴᖅᓯᒪᓚᐅᖅᑐᖅ ᖃᐅᔨᓴᕐᓂᐅᔪᓂᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᑲᒻᐸᓂᐃᑦ ᐅᖃᐅᓯᖃᖅᑕᖏᓐᓂᒃ ᐱᐅᓂᖅᓴᐅᔪᓂᒃ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒧᑦ. ᓇᓗᓇᐃᖅᓯᒪᓚᐅᖅᑐᖅ ᐊᒥᓱᓂᒃ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒥᒃ ᐃᓄᑦ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖏᓐᓂᒃ ᐱᓕᕆᖃᑦᑕᖅᑕᖏᓐᓂ, ᐊᒥᓲᙱᓐᓂᖅᓴᒥᒃ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒥᒃ ᖃᓂᒋᔭᖏᓐᓄᑦ ᐱᓕᕆᐊᓄᑦ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖏᓐᓂᒃ, ᐊᒻᒪ ᒥᑭᔪᒥᒃ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒥᒃ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐅᓪᓗᑕᒫᒧᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒥᒃ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑕᐅᔪᓂᕐᒧᑦ. ᖃᐅᔨᓴᕐᓂᐅᔪᑦ ᐊᒥᓱᑦ ᐋᖅᑭᒃᓱᐃᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᐱᔭᕇᖅᓯᒪᔪᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑎᑦᑎᓪᓗᑎᒃ (Simons ᐊᒻᒪ ᐃᓚᖏᑦ, Psychological Science in the Public Interest).
ᖃᐅᔨᓴᕐᓂᐅᔪᑦ ᑲᑎᑕᐅᓯᒪᔪᑦ ᖃᓄᖅ ᐅᖃᖅᐸᑦ ᖃᕋᓴᐅᔭᒃᑯᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ?
Cochrane ᖃᐅᔨᓴᕐᓂᐅᔪᑦ, ᐱᐅᓂᖅᓴᐅᔪᓂᒃ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᓂᒃ ᑲᑎᑦᑎᓲᑦ, ᖃᐅᔨᓴᖅᓯᒪᓚᐅᖅᑐᑦ ᖃᕋᓴᐅᔭᒃᑯᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒥᒃ 12-ᓂᒃ ᐱᓇᓱᐊᕈᓯᓂᒃ ᐅᖓᑖᓂᒃ ᐊᕐᕌᒍᓂᒃ ᐱᓕᕆᖃᑦᑕᖅᑕᐅᓯᒪᔪᒥᒃ:
- ᖃᓄᐃᖏᑦᑎᐊᖅᑐᑦ ᐃᓄᒃᑏᑦ 65-ᓂᒃ ᐅᑭᐅᖃᕐᓂᖅᓴᐅᔪᑦ: ᓯᑎᒐᖅ ᖃᐅᔨᓴᕐᓂᐅᔪᑦ 1,183-ᓂᒃ ᐃᓄᓐᓂᒃ. ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖏᑦ ᐊᔪᕐᓇᖅᑐᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐊᔪᕐᓇᖅᑐᒻᒪᕆᐅᔪᑦ. ᒥᑭᔪᒥᒃ ᐃᑲᔪᖅᑐᖅ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐱᔭᕇᖅᑎᓪᓗᒍ ᑕᑯᔭᐅᔪᓐᓇᖅᑐᖅ, ᐊᑯᓂᐅᔪᒧᑦ ᐊᑐᖅᑕᐅᓂᖓ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᖃᙱᑦᑐᖅ (Cochrane ᖃᐅᔨᓴᕐᓂᖅ, ᖃᓄᐃᖏᑦᑎᐊᖅᑐᑦ ᐃᓄᒃᑏᑦ).
- ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖃᕐᑐᑦ: ᓯᑎᒐᖅ ᖃᐅᔨᓴᕐᓂᐅᔪᑦ 660-ᓂᒃ ᐃᓄᓐᓂᒃ. ᖃᐅᔨᓴᕐᓂᐅᔪᓂᒃ ᐊᑕᐅᓯᖅᓯᓐᓇᖅ ᐅᖃᐅᓯᖃᙱᓚᖅ ᑭᓇᐅᔾᔪᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᐱᔭᕆᐊᖃᖅᐸᑦ, ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖏᓪᓗ ᓴᙱᓂᖅᓴᐅᓚᐅᖅᑐᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᕐᒧᑦ (Cochrane ᖃᐅᔨᓴᕐᓂᖅ, ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖃᕐᑐᑦ).
ACTIVE ᖃᐅᔨᓴᕐᓂᖅ ᖃᓄᖅ ᓇᓗᓇᐃᖅᓯᓚᐅᖅᐸ?
ACTIVE ᐊᖏᔪᖅ ᐊᒥᐊᓕᑲᒥ ᖃᐅᔨᓴᕐᓂᐅᔪᖅ 1998-ᒥ ᐱᒋᐊᖅᑐᖅ 2,802-ᓂᒃ ᐃᓄᓐᓂᒃ 65-ᓂᒃ ᐅᑭᐅᖃᕐᓂᖅᓴᐅᔪᓂᒃ ᓇᖕᒥᓂᖃᕐᓱᑎᒃ ᐃᓅᓯᒃᑯᑦ ᐊᒻᒪ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖃᙱᑦᑐᓂᒃ. ᐃᓄᑦ ᐊᔾᔨᒌᙱᑦᑎᐊᖅᑐᒃᑯᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐱᖓᓱᓄᑦ ᐊᔾᔨᒌᙱᑦᑐᓄᑦ ᑎᒥᐅᔪᑦ (ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ, ᐃᖅᑲᐅᒪᔭᐅᓂᖅ, ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒋᔭᐅᓂᖅ) ᐅᕝᕙᓘᓐᓃᑦ ᐃᓕᓐᓂᐊᕐᓂᖃᙱᑦᑐᓄᑦ ᑲᑎᙵᔪᓄᑦ. ᐃᓕᓐᓂᐊᕐᓂᖅ ᖁᓕᓄᑦ ᐃᓕᓐᓂᐊᕐᓂᐅᔪᓐᓇᓚᐅᖅᑐᖅ ᑕᓪᓕᒪᓄᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐱᖓᓱᓄᑦ ᐱᓇᓱᐊᕈᓯᓄᑦ. ᐃᓚᖏᑦ ᐃᓕᓐᓂᐊᕐᓂᐅᔪᓂᒃ ᐱᔭᕇᖅᓯᒪᔪᑦ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓂᒃ ᐃᓕᓐᓂᐊᕐᓂᕐᓂᒃ ᐅᖃᐅᓯᖃᖅᑐᑦ ᐊᕐᕌᒍ ᐊᑕᐅᓯᕐᒧᑦ ᐊᒻᒪ ᐱᖓᓱᓄᑦ ᐊᕐᕌᒍᓄᑦ ᑭᖑᓪᓕᖅᐹᒥ.
ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᑕᑯᓂᕐᒧᑦ ᑐᑭᓕᐅᕐᓂᕐᒧᑦ ᑐᓴᖅᑕᐅᔪᓂᒃ ᓱᒃᑲᓂᖅᓴᐅᑎᑦᑎᓂᖅ ᓇᐃᑦᑐᓂᒃ ᑕᑯᓂᕐᓂ, ᐊᔪᕐᓇᓂᖓ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑦᑎᓪᓗᒍ.
2026-ᒥ, ᖃᐅᔨᓴᖅᑏᑦ 2,021-ᓂᒃ ᐃᓚᐅᖃᑕᐅᓯᒪᔪᓂᒃ Medicare ᑎᑎᖅᑲᖏᓐᓄᑦ 20-ᓂ ᐅᑭᐅᓂ ᑐᑭᓯᓇᓱᒃᑎᓚᐅᖅᐳᑦ (ACTIVE 20-ᓂ ᐅᑭᐅᓂ ᖃᐅᔨᓴᕐᓂᖅ). ᐅᕙᓂ ᓇᓗᓇᐃᖅᓯᒪᔪᑦ ᑕᑯᔭᐅᓯᒪᔪᑦ:
- ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒻᒪ ᐊᑕᐅᓯᕐᒥᒃ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᒥᒃ ᐃᓕᓐᓂᐊᕐᓂᖅ: ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᓯᒪᓂᖏᑦ ᐊᒥᓲᓂᖅᓴᐅᓚᐅᖅᐳᑦ ᐃᓕᓐᓂᐊᕐᓂᖃᙱᑦᑐᓂᒃ ᑲᑎᙵᔪᓄᑦ ᐊᔾᔨᒌᒃᑐᑦ (hazard ratio 0.75, ᐃᒪᓐᓇ 25% ᒥᑭᓪᓕᓂᖅ).
- ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᓂᖃᙱᑦᑐᖅ: ᒥᑭᓪᓕᓂᖃᙱᓚᖅ.
- ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ: ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᓯᒪᓂᕐᒧᑦ ᐊᑐᖅᑕᐅᓯᒪᔪᖃᙱᓚᖅ.
- ᐃᓕᓐᓂᐊᕐᓂᐅᔪᑦ ᑲᑎᙵᔪᑦ ᑕᒪᐃᓐᓂᒃ ᐃᓕᓐᓂᐊᕐᓂᖃᙱᑦᑐᓂᒃ ᑲᑎᙵᔪᓄᑦ ᐊᔾᔨᒌᒃᑐᑦ: ᒥᑭᓪᓕᓂᕐᒧᑦ ᐃᓱᒪᓕᒃᓴᖅ ᑕᑯᔭᐅᓚᐅᖅᑐᖅ, ᑭᓯᐊᓂ ᓈᓴᐅᑎᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᖃᙱᓚᖅ.
ᑖᓐᓇ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ ᑭᓪᓕᓯᓂᐊᖅᑕᖏᑦ
- ᑖᓐᓇ ᐊᑐᖅᑐᖅ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᒥᒃ ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓄᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᓄᑦ, ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᓄᑦ ᑕᒪᐃᓐᓄᑦ ᐱᙱᑦᑐᖅ.
- ᓈᓴᐅᑎᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᖅ ᐱᔭᐅᓚᐅᖅᑐᖅ ᐃᓚᒋᔭᐅᔪᓂᒃ (ᐃᓕᓐᓂᐊᕐᓂᐅᔪᓂᒃ ᐱᔭᕇᖅᓯᒪᔪᑦ ᐊᒻᒪ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓂᒃ ᐃᓕᓐᓂᐊᕐᓂᕐᓂᒃ ᐱᔭᐅᔪᑦ), ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᐅᔪᓂᒃ ᑲᑎᙵᔪᓂᒃ ᑕᒪᐃᓐᓂᒃ ᐱᙱᑦᑐᖅ.
- ᐳᕆᓐᓇᐃᔭᕐᓂᖅ ᓇᓗᓇᐃᔭᐅᓯᒪᓚᐅᖅᑐᖅ Medicare ᓇᓗᓇᐃᖅᓯᓯᒪᓂᕐᒧᑦ ᓇᓗᓇᐃᒃᑯᑕᐅᔪᓂᒃ, ᐃᓄᓐᓂᒃ ᑕᒪᐃᓐᓂᒃ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᓂᖃᙱᑦᑐᑦ. ᐱᒋᐊᕐᕕᖕᒥ ᐃᓚᐅᖃᑕᐅᓯᒪᔪᑦ 25% ᒥᓯᒃᑲᐅᑎᑕᐅᓯᒪᔪᑦ ᑕᒪᒃᑯᐊ Medicare Advantage-ᒥ ᐃᓚᐅᖃᑕᐅᓯᒪᓪᓗᑎᒃ.
- ᐃᓚᐅᖃᑕᐅᓯᒪᔪᑦ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖃᙱᓚᐅᖅᑐᑦ ᐱᒋᐊᕐᓂᕐᒥ. ᖃᓄᖅ ᐱᔭᐅᓯᒪᓂᖏᑦ ᐱᙳᐊᕈᑎᓄᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᐃᓅᔪᓄᑦ ᐅᖃᐅᓯᖃᙱᑦᑐᑦ.
ᑖᓐᓇ ᐱᔪᒪᓂᖅᓴᐅᔪᖅ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᐱᔭᐅᔪᓐᓇᖅᑐᖅ. ᐱᙳᐊᕈᑎᒥᒃ ᐊᑕᐅᓯᕐᒥᒃ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᖓ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖃᙱᑦᑐᖅ.
FTC ᖃᓄᖅ ᐅᖃᓚᐅᖅᐸ Lumosity-ᒧᑦ?
ᔮᓄᐊᕆ 2016-ᒥ, Lumos Labs, Lumosity-ᒧᑦ ᓴᓇᔨᖏᑦ, ᐊᖏᖃᑎᒌᒃᓯᒪᓚᐅᖅᑐᖅ $2 ᒥᓕᐊᓐ ᐊᑭᓕᖅᓱᒃᑎᑦᑎᓂᕐᒧᑦ Federal Trade Commission ᐱᔾᔪᑎᖃᖅᓯᒪᓂᖏᓐᓄᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᙱᑦᑐᓂᒃ ᐅᖃᐅᓯᖃᕐᓂᕐᒧᑦ. FTC ᐅᖃᓚᐅᖅᑐᖅ ᑲᒻᐸᓂ ᐅᖃᐅᓯᖃᖅᓯᒪᓂᖏᓐᓂᒃ, ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖃᙱᑦᑐᑦ, ᐱᙳᐊᕈᑎᖏᑦ ᐃᖅᑲᓇᐃᔭᕐᕕᒻᒥ ᐊᒻᒪ ᐃᓕᓐᓂᐊᕐᕕᒻᒥ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᑎᑕᐅᔪᓐᓇᖅᑐᑦ ᐊᒻᒪ ᐃᓐᓇᐅᔭᕐᓂᕐᒧᑦ ᐊᑐᖅᑐᒥᒃ ᒥᑭᓪᓕᓂᖅ, ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖅ, ᐳᕆᓐᓇᐃᔭᕐᓂᖅ ᐊᒻᒪ ᐋᓐᑐᐃᒪ ᓄᖅᑲᖅᑎᑕᐅᔪᓐᓇᖅᑐᑦ. ᐊᖏᖃᑎᒌᒍᑎᖅ ᐱᔾᔪᓯᖃᖅᑐᖅ ᑲᒻᐸᓂ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᓂᒃ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᐱᔭᕆᐊᖃᕐᓂᕐᒧᑦ ᓯᕗᓂᒃᓴᒥ ᑕᐃᒪᐃᓐᓇᖅ ᐅᖃᐅᓯᖃᕐᓂᐊᕐᒥᓂ (FTC ᑐᓴᖅᑎᑦᑎᔾᔪᑎ).
ᐃᓚᒌᒍᑎᖓ ᐃᓄᓐᓄᑦ: ᐅᔾᔨᕆᔭᖃᕐᓗᑎᑦ ᐱᙳᐊᕈᑎᒥᒃ, ᐱᙳᐊᕈᑎᒧᑦ ᐊᑐᖅᑕᐅᔪᒥᒃ ᐅᕝᕙᓘᓐᓃᑦ ᐱᓕᕆᐊᒥᒃ ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒥᒃ ᓴᐳᔾᔭᐅᓯᒪᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᕐᒧᑦ ᐅᖃᐅᓯᖃᖅᐸᑦ.
ᐱᙳᐊᕈᑎᑦ ᐃᑲᔪᕈᓐᓇᖅᐸᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓅᔪᒥᒃ?
ᐅᓪᓗᖅ ᐱᐅᓂᖅᓴᐅᑎᑦᑎᔪᓐᓇᖅᑐᑦ, ᑖᓐᓇ ᐱᒻᒪᕆᐅᔪᖅ. ᐱᐅᓂᖅᓴᐅᖅᑐᒃᑯᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᖅ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᖅ: ᖁᕕᐊᓱᒍᑎᒧᑦ ᑲᑎᙵᔪᓂ ᐱᓕᕆᐊᑦ, ᐅᖃᖃᑎᒌᓐᓂᖅ, ᐃᖅᑲᐅᒪᔭᐅᓂᖅ, ᐅᖃᐅᓯᓕᕆᓂᖅ, ᐱᙳᐊᕈᑎᑦ, ᐃᙱᖅᑎᑦᑎᓂᖅ ᐊᒻᒪ ᐅᖃᖃᑎᒌᓐᓂᖅ, ᒥᑭᔪᓂ ᑲᑎᙵᔪᓂ ᐃᓕᑕᐅᓯᒪᔪᓂ.
2023-ᒥ Cochrane ᖃᐅᔨᓴᕐᓂᖅ 37-ᓂᒃ ᖃᐅᔨᓴᕐᓂᐅᔪᓂᒃ 2,766-ᓂᒃ ᐃᓄᓐᓂᒃ ᐊᔪᕐᓇᖅᑐᓂᒃ ᒥᑭᔪᓂᒃ ᐊᒻᒪᓗ ᐊᑯᓐᓂᖓᓂ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᓇᓗᓇᐃᖅᓯᓚᐅᖅᑐᖅ (Cochrane ᖃᐅᔨᓴᕐᓂᖅ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᕐᒧᑦ):
- ᒥᑭᔪᒥᒃ, ᓇᐃᑦᑐᒥᒃ ᐃᑲᔪᖅᑐᖅ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᖃᐅᔨᓴᖅᑕᐅᓂᕐᒧᑦ (ᐊᑯᓐᓂᖓᓂ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ);
- ᐱᒻᒪᕆᐅᔪᓂᒃ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖅ ᐅᖃᖃᑎᒌᓐᓂᕐᒧᑦ ᐊᒻᒪ ᐃᓄᖕᓂᒃ ᐃᓚᐅᖃᑕᐅᓂᕐᒧᑦ (ᖁᑦᑎᖕᓂᖅᓴᐅᔪᖅ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ, ᒥᑭᔪᓂᒃ ᖃᐅᔨᓴᕐᓂᐅᔪᓂᒃ);
- ᒥᑭᔪᓂᒃ ᐃᑲᔪᖅᑐᑦ ᐃᓅᓯᕐᒧᑦ ᖃᓄᐃᓕᖓᓂᕐᒧᑦ, ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᒻᒪ ᐱᓕᕆᐊᒥᒃ.
ᐃᑲᔪᖅᑐᑦ ᓇᓗᓇᐃᔭᐅᓯᒪᓚᐅᖅᑐᑦ ᐱᓕᕆᐊᑦ ᐱᔭᕇᖅᑎᓪᓗᒋᑦ ᐊᒻᒪ ᖁᓕᓂᒃ ᐱᓇᓱᐊᕈᓯᓂᒃ ᐱᓕᕆᐊᓂ, ᐊᒥᓱᙱᑦᑐᑦ ᖃᐅᔨᓴᕐᓂᐅᔪᑦ ᖃᐅᔨᓴᖅᓯᒪᙱᓚᐅᖅᑐᑦ ᐊᑯᓂᐅᔪᒧᑦ ᐊᑐᖅᑕᐅᓂᖏᓐᓂᒃ. ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᖅ ᑲᑎᙵᔪᓂ ᐱᓕᕆᐊᖅ, ᑕᐃᒪᐃᒻᒪᑦ ᑖᒃᑯᐊ ᖃᓄᖅ ᐱᔭᐅᓯᒪᓂᖏᑦ ᐃᓄᖅ ᐃᓄᒃᑎᑐᑦ ᐱᙳᐊᕈᑎᒥᒃ ᐱᓕᕆᐊᖃᑦᑕᖅᐸᑦ ᖃᕋᓴᐅᔭᒃᑯᑦ ᐊᑐᖅᑕᐅᔪᒥ ᐊᑐᖅᑕᐅᔪᓐᓇᙱᑦᑐᑦ.
2024-ᒥ Lancet ᑲᒥᓯᐊᓂᓪᓗ ᐅᖃᖅᑐᖅ ᐱᓕᕆᐊᑦ ᐱᒻᒪᕆᐅᔪᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᒃ ᐃᓅᔪᓄᑦ, ᖁᕕᐊᓱᒍᑎᒥᒃ ᐊᒻᒪ ᐱᔾᔪᑎᖃᕐᓂᕐᒥᒃ ᐱᔭᐅᖃᑦᑕᕐᓂᕐᒧᑦ (Lancet ᑲᒥᓯᐊᓂ).
ᐱᙳᐊᕈᑎᑦ ᐱᔭᐅᒻᒪᕆᐅᓲᑦ ᖃᓄᖅ?
ᓂᕈᐊᖅᑕᐅᒃᑲᓐᓂᕈᒪᒃᐸᑦ, ᐱᙳᐊᕈᑎᑦ ᑐᓂᔪᓐᓇᖅᑐᑦ:
- ᖁᕕᐊᓱᒍᑎ. ᖁᕕᐊᓱᒍᑎᒧᑦ ᐃᑲᐃᓐᓇᐅᔭᕐᓂᖅ ᐱᒻᒪᕆᐅᔪᖅ.
- ᑲᑎᙵᓂᖅ. ᓴᓂᖃᑎᒌᓐᓂᕐᒧᑦ ᐱᙳᐊᕈᓂᖅ ᐅᖃᖃᑎᒌᓐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᐸᑦ ᐊᑐᖅᑕᐅᔪᓐᓇᖅᑐᖅ. ᑕᑯᓗᒍ ᖃᓄᖅ ᑲᑎᙵᓂᕐᒧᑦ ᐱᙳᐊᕈᓂᖅ.
- ᐱᓕᕆᐊᖅ. ᓇᓗᓇᐃᔭᖅᓯᒪᔪᒥᒃ ᐱᓕᕆᐊᒥᒃ ᐅᓪᓗᑕᒫᑦ ᐊᑯᓐᓂᖓᓂ ᑕᐃᒪᐃᑦᑐᒥ ᓴᐳᒻᒥᕚᐅᓂᖅ ᐱᔭᐅᔪᓐᓇᖅᑐᖅ.
- ᐃᓕᒃᑲᓐᓂᕐᓂᖅ. ᐃᓄᐃᑦ ᐱᔪᓐᓇᑦᑎᐊᕐᓂᖏᓐᓄᑦ ᐊᑐᖅᑕᐅᔪᑦ ᐱᓕᕆᐊᑦ ᐱᔪᓐᓇᖅᑎᑦᑎᕗᑦ, ᖃᐅᔨᓴᖅᑕᐅᓂᖃᙱᑦᑐᑦ.
- ᐅᖃᖃᑎᒌᓐᓂᖅ. ᐊᔾᔨᙳᐊᖅ ᐅᕝᕙᓘᓐᓃᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᖅ ᐅᖃᐅᓯᖅ ᐅᓂᒃᑳᕐᓂᕐᒧᑦ ᒪᑐᐃᖅᑎᑕᐅᔪᓐᓇᖅᑐᖅ. ᐆᒃᑐᒃᑲᓐᓂᕐᓗᒍ ᐅᖃᖃᑎᒌᓐᓂᕐᒧᑦ ᐱᖃᐅᑎᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐅᖃᐅᓯᖅ ᐱᔭᕇᖅᓯᓂᖅ.
ᐊᑐᖅᑕᐅᔪᓐᓇᙱᑦᑐᑦ: ᐱᕕᖃᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᒃᑯᑕᐅᔪᑦ, ᓈᓴᐅᑏᑦ, ᐊᒻᒪ ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᖃᐅᔨᓴᖅᑕᐅᓂᕐᒧᑦ ᐊᔾᔨᒌᙱᑦᑐᑦ. ᐃᓄᖅ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᓕᒃᐸᑦ, ᓄᖅᑲᕆᑦ. ᐱᔭᕇᖅᓯᓂᖅ ᓯᕗᓪᓕᖅᐹᒥ, ᐅᕝᕙᓘᓐᓃᑦ ᑲᑎᙵᓂᕐᒧᑦ ᐃᖃᓗᑎᒃ, ᐱᐅᔪᖅ ᖃᓄᐃᓕᖓᓂᖅ. ᐅᕙᓂ ᐊᑐᖅᑕᐅᔪᖅ ᐅᖃᐅᓯᖃᖅᑐᖅ ᐱᙳᐊᕈᑎᓂᒃ ᐊᒻᒪ ᐱᓕᕆᐊᓂᒃ ᓂᕈᐊᕐᓂᖅ ᑎᑎᕋᖅᓯᒪᔪᓂᒃ ᐱᔭᕆᐊᖃᖅᑐᖅ.
Golden Moments ᓇᓃᑦᑐᖅ
Golden Moments ᐱᙳᐊᕈᑎᖏᑦ, ᓲᕐᓗ ᐊᔾᔨᙳᐊᓂᒃ ᓇᓕᐊᖕᓄᑐᐃᓐᓇᖅ, ᐊᔾᔨᙳᐊᓂᒃ ᐃᓚᓯᐊᕈᓐᓇᙱᑦᑎᓂᖅ ᐊᒻᒪ ᐊᖏᔪᓂᒃ ᑎᑎᕋᖅᓯᒪᔪᓂᒃ ᐅᖃᐅᓯᓕᕆᓂᖅ, ᓴᓇᔭᐅᓯᒪᔪᑦ ᖁᕕᐊᓱᒍᑎᒧᑦ ᐊᒻᒪ ᑲᑎᙵᓂᕐᒧᑦ. ᐱᕕᖃᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᒃᑯᑕᐅᔪᖃᙱᑦᑐᑦ ᓈᓴᐅᑎᓪᓗ ᐱᑕᖃᙱᑦᑐᖅ. ᒪᒪᕐᓂᐅᑎᙱᑦᑐᑦ, ᐊᒻᒪ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓲᑦ ᐅᕝᕙᓘᓐᓃᑦ ᓱᒃᑲᓂᖅᓴᐅᑎᑕᐅᓲᑦ. ᑕᐃᒪᐃᓐᓇᖅ ᐅᖃᕈᒪᕗᒍᑦ ᐱᙳᐊᕈᑎᒥᒃ ᐊᑕᐅᓯᕐᒥᒃ ᑐᓂᔭᐅᔪᓐᓇᙱᑦᑐᒥᒃ ᐅᖃᐅᓯᖃᕐᓂᕐᒧᑦ.
ᒪᒪᕐᓂᐅᕐᑎᒧᑦ ᐅᖃᖃᑎᒌᓐᓂᖅ
ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᐊᓯᔾᔨᕐᓂᕐᒧᑦ ᐃᓕᒃᑲᓐᓂᕐᓂᖅ ᐃᓕᒃᑲᓐᓂᕐᐸᑦ, ᐅᕝᕙᓘᓐᓃᑦ ᐸᐅᕐᓯᒪᒃᑕᑦ ᐃᓄᐃᑦ ᐃᖅᑲᐅᒪᔭᐅᓂᖏᓐᓄᑦ, ᒪᒪᕐᓂᐅᕐᑎᒧᑦ ᑕᑯᔭᐅᕆᑦ, ᐱᙳᐊᕈᑎᒧᑦ ᐊᑐᖅᑕᐅᔪᒧᑦ ᑐᕌᖓᑎᑕᐅᙱᑦᑐᖅ. ᒪᒪᕐᓂᐅᕐᑎ ᖃᐅᔨᓴᕐᓂᖅ ᐱᔪᓐᓇᖅᑐᖅ ᒪᒪᕐᓂᐅᑎᑕᐅᔪᓐᓇᖅᑐᓂᒃ ᐱᔾᔪᑎᓂᒃ ᐊᒻᒪ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᓂᒃ ᐊᑐᖅᑕᐅᔪᓂᒃ ᐅᖃᖃᑎᒌᒃᑎᑦᑎᔪᓐᓇᖅᑐᖅ, ᓲᕐᓗ ᐊᐅᒃᓴᐅᑎᒧᑦ ᐊᐅᓚᑦᑎᓂᖅ ᐊᒻᒪ ᑐᓵᔪᓂᖅ ᖃᐅᔨᓴᕐᓂᖅ. ᑕᑯᓗᒍ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᔪᓐᓇᖅᐸ? ᑐᑭᓯᒋᐊᕈᒪᒃᐸᑦ. ᑕᒻᒪᕇᒃᑐᒥᒃ ᐃᓱᒪᓕᒃᓯᒪᓂᖅ ᐅᕝᕙᓘᓐᓃᑦ ᑕᒻᒪᕇᒃᑐᒥᒃ ᐊᓯᔾᔨᕐᓂᖅ ᐱᔾᔪᑎᖃᖅᐸᑦ, ᒪᒪᕐᓂᐅᕐᑎᒧᑦ ᐃᑲᔪᖅᑐᒥᒃ ᕿᓂᕐᓗᑎᑦ ᑲᔪᓰᓐᕕᒃ.
ᐊᐱᖅᑯᑕᐅᒐᔪᒃᑐᑦ
ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᐋᓐᑐᐃᒪ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓲᑦ?
ᐱᙳᐊᕈᑎᒥᒃ ᐊᑕᐅᓯᕐᒥᒃ ᐋᓐᑐᐃᒪ ᐅᕝᕙᓘᓐᓃᑦ ᐊᓯᖏᓐᓂᒃ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᑕᐅᓂᖓ ᓇᓗᓇᐃᖅᓯᒪᔪᖃᙱᑦᑐᖅ. National Institute on Aging ᐅᖃᖅᑐᖅ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᓂᒃ ᓈᓴᐅᑎᓂᒃ ᐊᒥᓱᓂᖅᓴᐅᙱᑦᑐᑦ ᓂᐅᕕᐊᒃᓴᖃᕐᓂᕐᒧᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐱᙳᐊᕈᑎᑦ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᓂᒃ ᐊᔾᔨᒌᙱᑦᑐᑦ. ᐱᙳᐊᕈᑎᑦ ᖁᕕᐊᓱᒍᑎᐅᔪᓐᓇᖅᑐᑦ ᐱᕕᖃᕐᓂᕐᒧᑦ.
ACTIVE ᖃᐅᔨᓴᕐᓂᖅ ᖃᓄᖅ ᓇᓗᓇᐃᖅᓯᓚᐅᖅᐸ ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᒻᒪ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ?
2026-ᒥ ᖃᐅᔨᓴᕐᓂᖅ ACTIVE-ᒥ ᐃᓚᐅᖃᑕᐅᓯᒪᔪᓂᒃ Medicare ᑎᑎᖅᑲᓂᒃ 20-ᓂ ᐅᑭᐅᓂ ᑐᑭᓯᓇᓱᒃᑎᓚᐅᖅᐳᖅ. ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐊᒻᒪ ᐊᑕᐅᓯᕐᒥᒃ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᔪᓂᒃ ᐃᓕᓐᓂᐊᕐᓂᕐᒧᑦ ᐱᓕᕆᖃᑦᑕᖅᓯᒪᔪᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᓯᒪᓂᖏᑦ ᐊᒥᓲᓂᖅᓴᐅᓚᐅᖅᐳᑦ ᐃᓕᓐᓂᐊᕐᓂᖃᙱᑦᑐᓂᒃ ᑲᑎᙵᔪᓄᑦ ᐊᔾᔨᒌᒃᑐᑦ. ᓱᒃᑲᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐃᓚᒃᓴᐅᑎᑕᐅᓯᒪᓂᖃᙱᑦᑐᖅ, ᐃᖅᑲᐅᒪᔭᐅᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ, ᑕᑯᔭᐅᓯᒪᔪᖃᙱᓚᖅ.
ᐱᙳᐊᕈᑎᑦ ᐊᒻᒪ ᐱᓕᕆᐊᑦ ᐱᐅᔪᑦ ᐳᕆᓐᓇᐃᔭᕐᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓅᔪᒧᑦ?
ᐱᐅᔪᓐᓇᖅᑐᑦ, ᐃᓄᖅ ᖁᕕᐊᓱᒃᐸᑦ. ᑲᑎᙵᔪᓂ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐃᓕᑕᐅᓂᖅ, ᐅᖃᐅᓯᓕᕆᓂᖅ, ᐃᖅᑲᐅᒪᔭᐅᓂᖅ, ᐱᙳᐊᕈᑎᑦ, ᐃᙱᖅᑎᑦᑎᓂᖅ ᐊᒻᒪ ᐅᖃᖃᑎᒌᓐᓂᖅ ᐃᓚᒋᔭᐅᔪᑦ, ᒥᑭᔪᓂᒃ ᓇᐃᑦᑐᓂᒃ ᐊᑐᖅᑕᐅᔪᓂᒃ ᐃᑲᔪᖅᑐᖅ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᒻᒪ ᐅᖃᖃᑎᒌᓐᓂᕐᒧᑦ ᐃᓚᐅᖃᑕᐅᓂᕐᒧᑦ. ᖁᕕᐊᓱᒍᑎᖅ, ᖃᐅᔨᓴᖅᑕᐅᓂᖅ ᐱᔾᔪᑎᖓ ᐱᙱᑦᑐᖅ, ᑐᕌᒐᖃᕐᑎᑕᐅᔪᖅ.
ᓱᒃᑲᐃᓐᓇᕐᒧᑦ Lumosity ᐊᑭᓕᖅᓱᖅᑕᐅᓚᐅᖅᐸ FTC-ᒧᑦ?
2016-ᒥ Federal Trade Commission ᐱᔾᔪᑎᖃᖅᓯᒪᓚᐅᖅᑐᖅ Lumos Labs ᐅᖃᐅᓯᖃᖅᓯᒪᓂᖏᓐᓂᒃ ᐱᙳᐊᕈᑎᖏᑦ ᒥᒃᓵᓄᑦ, ᐃᓚᒋᔭᐅᓪᓗᑎᒃ ᐃᖅᑲᓇᐃᔭᕐᓂᕐᒥ ᐊᒻᒪ ᐃᓕᓐᓂᐊᕐᕕᒻᒥ ᐱᐅᓯᒋᐊᕐᓂᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᒻᒪ ᐃᓐᓇᐅᔭᕐᓂᕐᒧᑦ ᐊᑐᖅᑐᒥᒃ ᒥᑭᓪᓕᓂᖅ, ᐊᔪᕐᓇᖅᑐᒥᒃ ᐃᓱᒪᒋᔭᐅᓂᕐᒧᑦ ᐊᔪᕐᓇᖅᑐᓂᖅ ᐊᒻᒪ ᐳᕆᓐᓇᐃᔭᕐᓂᖅ, ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖃᙱᑦᑐᑦ. ᑲᒻᐸᓂ ᐊᖏᖃᑎᒌᒃᓯᒪᓚᐅᖅᑐᖅ $2 ᒥᓕᐊᓐ ᐊᑭᓕᖅᓱᒃᑎᑦᑎᓂᕐᒧᑦ ᐊᒻᒪ ᓇᓗᓇᐃᔭᖅᓯᒪᔪᓂᒃ ᖃᐅᔨᓴᕐᓂᕐᒧᑦ ᐱᔭᕆᐊᖃᕐᓂᕐᒧᑦ ᓯᕗᓂᒃᓴᒥ ᑕᐃᒪᐃᓐᓇᖅ ᐅᖃᐅᓯᖃᕐᓂᐊᕐᒥᓂ.
ᓇᑭᙶᕐᓂᖏᑦ
ᑐᕌᕈᑎᖃᖅᐳᒍᑦ ᑲᑐᔾᔨᖃᑎᒌᓄᑦ ᐊᒻᒪ ᖃᐅᔨᓴᕈᑕᐅᓯᒪᔪᓄᑦ ᑕᕝᕙᓂ ᒪᒃᐱᒐᕐᒥ ᑐᙵᕕᒋᔭᐅᔪᓄᑦ. ᐊᑐᓂ ᖃᐅᔨᓴᖅᑕᐅᓚᐅᖅᑐᑦ ᒪᒃᐱᒐᖅ ᓄᑖᙳᕆᐊᖅᑕᐅᑎᓪᓗᒍ.
- Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study · Alzheimer's & Dementia: Translational Research & Clinical Interventions (via PMC)
- Cognitive stimulation to improve cognitive functioning in people with dementia · Cochrane Database of Systematic Reviews (via PubMed)
- Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life · Cochrane Database of Systematic Reviews (via PubMed)
- Computerised cognitive training for preventing dementia in people with mild cognitive impairment · Cochrane Database of Systematic Reviews (via PubMed)
- Do "Brain-Training" Programs Work? · Psychological Science in the Public Interest
- Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges for Its "Brain Training" Program · Federal Trade Commission
- Preventing Alzheimer's Disease: What Do We Know? · National Institute on Aging
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission · The Lancet